Drugs / BMS-866949
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00949767 | Jul 2009 → Mar 2010 | depressive disorder | Bristol-Myers Squibb | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01124344 Comparator | May 2010 → Nov 2011 | major depressive disorder | Bristol-Myers Squibb | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS-866949 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01124344 ↗ |
| Route | Oral | “Oral Solution, Oral, once, 14 days” NCT00949767 ↗ |